Futura Medical (LON:FUM) Releases Earnings Results

Futura Medical (LON:FUM) posted its quarterly earnings results on Tuesday. The company reported GBX (0.20) EPS for the quarter, Digital Look Earnings reports. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%.

Futura Medical Stock Performance

Futura Medical stock opened at GBX 0.22 on Friday. Futura Medical has a one year low of GBX 0.20 and a one year high of GBX 10.45. The firm has a market capitalization of £1.28 million, a P/E ratio of -0.08 and a beta of 0.02. The company has a 50-day simple moving average of GBX 0.41 and a 200-day simple moving average of GBX 0.78.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.